2013 BIOCOM Board of Directors

CHAIR: Magda Marquet, Ph.D., Althea Technologies*

VICE CHAIR: Stephen Ferruolo, J.D., Ph.D., USD School of Law*

CHAIR ELECT: Theodore Schroeder, Cadence Pharmaceuticals*

VICE PRESIDENT AND GENERAL COUNSEL: Lisa Haile, J.D., Ph.D., DLA Piper*

VICE PRESIDENT – FINANCE: Daniel Kleeburg, Ernst & Young*

VICE PRESIDENT AND SECRETARY: Carin Canale-Theakston, Canale Communications*

VICE PRESIDENT – INDUSTRY: Daniel Burgess, Rempex Pharmaceuticals*

CHAIR EMERITUS: David Webb, Ph.D.*

PRESIDENT AND CEO: Joseph D. Panetta, BIOCOM*

Scott Biel, Mintz, Levin, Cohn, Ferris, Glovsky & Popeo

Martin Birkhofer M.D., Bristol-Myers Squibb R&D

Remi Brouard, M.D., Sanofi R&D West Coast

Michael Brown, Stradling Yocca Carlson & Rauth

Terrence J. Bruggeman, BioTork, LLC

Timothy Caulfield, American Internet Services

John M. Dunn

Geoffrey S. Eich, Amgen

M. Wainwright Fishburn, Jr., Cooley LLP*

Don Fitzgerald, Genentech

Jack Florio, Brinson Patrick Securities

Scott Foote, Square 1 Bank

Alan Gold, BioMed Realty Trust

Jeffrey W. Guise, Ph.D., Wilson, Sonsini, Goodrich & Rosati

Terry Gregg, Dexcom

Jason Hannon, NuVasive

Richard Heyman, Ph.D., Aragon Pharmaceuticals

Jim Hinrichs, CareFusion

Elliot Hirshman, Ph.D., San Diego State University

Matthew Hudes, Deloitte LLP

Scott Huennekens, Volcano Corporation

Guy J. Iannuzzi, 321 Medical Launch

Brent D. Jacobs, Cushman & Wakefield

David Kabakoff, Ph.D., Sofinnova Ventures

Steve Kaldor, Ph.D., Quanticel

Michael Kamdar, Genoa Pharmaceuticals

Katherine Kantardjieff, Ph.D., California State University San Marcos

Richard Kaufman, Foley & Lardner

Paul Laikind, Ph.D., Viacyte

Kevin Larkin, TherOx

Jacob Levin, Ph.D., UC Irvine

James Levine, Verenium

Jack Lief, Arena Pharmaceuticals, Inc.*

Steven Mento, Ph.D., Conatus Pharmaceuticals, Inc.*

William Molloie, PwC

Paul Negulescu, Ph.D., Vertex Pharmaceuticals, Inc.*

Brian O'Callaghan, Sangart

John Parrish, BioVascular Inc.

Trindl Reeves, Barney & Barney LLC*

Gregory Reyes, M.D., Ph.D., Celgene

James Schaeffer, Ph.D., Merck Research Laboratories*

Christophe Schilling, Genomatica, Inc.*

Timothy Scott, Pharmatek Laboratories, Inc.*

Martin Seidel, Ph.D., Genomics Institute of the Novartis Research Foundation

Bhasker Shetty, Ph.D., Pfizer La Jolla

Larry Stambaugh, Centre for Bioinspiration, SD Zoo Global*

Mark Stevenson, Life Technologies*

Roger Stoll, Ph.D., Cortex Pharmaceuticals

Nikki Vogt, Deloitte LLP

Scott N. Wolfe, Latham & Watkins LLP

Lawrence Cohn, Stradling Yocca Carlson & Rauth

Randall E. Woods, Sophiris Bio*

Kleanthis Xanthopoulos, Ph.D., Regulus Therapeutics

LIFE DIRECTORS:

Kennon W. Baldwin, Ferguson Pape Baldwin Architects*

David Hale, Hale BioPharma Ventures*

Tina Nova, Ph.D., Genoptix, Inc

Duane J. Roth, CONNECT

Board Members-Ex-Officio:

David Brenner, M.D., UCSD School of Medicine

Mark Cafferty, SD Regional Economic Development Corp.

Constance Carroll, Ph.D., SD Community College District

Peter Preuss, The Preuss Foundation

Jerry Sanders, SD Regional Chamber of Commerce

Robert Sullivan, Ph.D., Rady School of Management, UCSD

*Executive Committee